Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Feasibility and Safety of Intensive Continuous Glycemic Control after Acute Ischemic Stroke
Cerebrovascular Disease and Interventional Neurology
(-)
101
Authors/Disclosures
Stefan H. Kreisel, MD No disclosure on file
No disclosure on file
No disclosure on file
Wolfgang Singer, MD, FÂé¶¹´«Ã½Ó³»­ (Mayo Clinic) Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. The institution of Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yoda. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
Sophia I. Thomopoulos (Imaging Genetics Center) No disclosure on file
No disclosure on file
Paola Sandroni, MD, PhD, FÂé¶¹´«Ã½Ó³»­ (Mayo Clinic) Dr. Sandroni has nothing to disclose.
No disclosure on file
No disclosure on file
Robert D. Fealey, MD (Mayo Clinic/Dept of Neuro) No disclosure on file
No disclosure on file
Elizabeth A. Coon, MD, FÂé¶¹´«Ã½Ó³»­ (Mayo Clinic) Dr. Coon has received publishing royalties from a publication relating to health care. Dr. Coon has a non-compensated relationship as a Non-Voting Member of the Board of Directors with UCNS that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Michael G. Hennerici, MD (Mannheim Universitats-Klinikum) No disclosure on file
Eduardo E. Benarroch, MD, FÂé¶¹´«Ã½Ó³»­ (Mayo Clinic) Dr. Benarroch has nothing to disclose.
Stefan Schwarz, MD (Central Institute of Mental Health, University of Heidelberg) No disclosure on file
Sarah E. Berini, MD (Mayo Clinic) Dr. Berini has nothing to disclose.
Michelle L. Mauermann, MD, FÂé¶¹´«Ã½Ó³»­ (Mayo Clinic) The institution of Dr. Mauermann has received research support from Intellia. Dr. Mauermann has received publishing royalties from a publication relating to health care.
David M. Sletten, MBA Mr. Sletten has nothing to disclose.
Phillip A. Low, MD, FÂé¶¹´«Ã½Ó³»­ (Mayo Clinic) Dr. Low has nothing to disclose.
Troy Lund No disclosure on file